Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon alpha in lymphoma.

A Z Rohatiner1

  • 1ICRF Department of Medical Oncology, St Bartholomew's Hospital, London.

British Journal of Haematology
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Studies are evaluating interferon alpha for follicular lymphoma, alone and with chemotherapy. Research also reviews interferon alpha

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Myelogenous Leukaemia in Patients 60 Years and Older: A Retrospective Analysis from St Bartholomew's Hospital 1969-1999.

Hematology (Amsterdam, Netherlands)·2016
Same author

Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia.

The hematology journal : the official journal of the European Haematology Association·2002
Same author

Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma.

The hematology journal : the official journal of the European Haematology Association·2002
Same author

Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis.

British journal of haematology·2001
Same author

Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia.

British journal of haematology·2001
Same author

Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Area of Science:

  • Oncology
  • Immunology
  • Hematology

Background:

  • Follicular lymphoma is a type of non-Hodgkin lymphoma.
  • Interferon alpha is a biologic therapy with immunomodulatory effects.
  • Cutaneous T-cell lymphoma (CTCL) is a diverse group of T-cell malignancies affecting the skin.

Purpose of the Study:

  • To review current research on interferon alpha in follicular lymphoma treatment.
  • To assess the efficacy of interferon alpha, both as monotherapy and in combination with chemotherapy.
  • To explore the potential role of interferon alpha in managing cutaneous T-cell lymphoma.

Main Methods:

  • Review of ongoing clinical studies.
  • Analysis of existing data on interferon alpha efficacy.
  • Literature synthesis on therapeutic applications in hematologic malignancies.

Related Experiment Videos

Main Results:

  • Multiple studies are actively investigating interferon alpha for follicular lymphoma.
  • Combination therapy with interferon alpha and chemotherapy is under evaluation.
  • Preliminary data suggests a potential role for interferon alpha in CTCL.

Conclusions:

  • Interferon alpha is a promising therapeutic agent for follicular lymphoma.
  • Further research is warranted to establish optimal treatment protocols.
  • Interferon alpha may offer a new treatment avenue for cutaneous T-cell lymphoma.